(Q43045517)

12 November 2017

title

Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia (English)

1 reference

12 November 2017

0 references

1

Robert H Pietrzak

1 reference

12 November 2017

Peter J Snyder

2

1 reference

12 November 2017

Paul Maruff

series ordinal

3

1 reference

12 November 2017

publication date

1 June 2010

1 reference

12 November 2017

published in

Human Psychopharmacology

1 reference

12 November 2017

volume

25

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

353-358

1 reference

12 November 2017

1 reference

Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers

21 January 2018

1 reference

7 January 2021

The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia

1 reference

7 January 2021

A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

1 reference

7 January 2021

Modulation of use-dependent plasticity by d-amphetamine

1 reference

7 January 2021

Cognition in the days following concussion: comparison of symptomatic versus asymptomatic athletes

1 reference

7 January 2021

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

1 reference

7 January 2021

Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals.

1 reference

7 January 2021

Effects of d-amphetamine in human models of information processing and inhibitory control

1 reference

7 January 2021

d-Amphetamine-induced enhancement of inhibitory mechanisms involved in visual search

1 reference

7 January 2021

The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine

1 reference

7 January 2021

Pharmacological treatment of cognition in schizophrenia: an idea whose method has come

1 reference

7 January 2021

The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization

1 reference

7 January 2021

Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex.

1 reference

7 January 2021

A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam.

1 reference

7 January 2021

Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study.

1 reference

7 January 2021

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

1 reference

7 January 2021

A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.

1 reference

7 January 2021

Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals.

1 reference

7 January 2021

Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers

1 reference

7 January 2021

The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance.

1 reference

7 January 2021

Effect of treatment with stimulant medication on nonverbal executive function and visuomotor speed in children with attention deficit/hyperactivity disorder (ADHD).

1 reference

7 January 2021

Changes in regional cerebral blood flow due to cognitive activation among patients with schizophrenia

1 reference

7 January 2021

Dexamphetamine enhances explicit new word learning for novel objects.

1 reference

7 January 2021

Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology

1 reference

7 January 2021

Dual modulating effects of amphetamine on neuronal excitability and stimulation-induced plasticity in human motor cortex

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.1118

1 reference

12 November 2017

1 reference